Abstract:Protein Arginine Methyltransferases (PRMTs) are a family of enzymes regulating protein arginine methylation, which is a post-translational modification crucial for various cellular processes. Recent studies have highlighted the mechanistic role of PRMTs in cancer pathogenesis, immunotherapy, and drug resistance. PRMTs are involved in diverse oncogenic processes, including cell proliferation, apoptosis, and metastasis. They exert their effects by methylation of histones, transcription factors, and other regulatory proteins, resulting in altered gene expression patterns. PRMT-mediated histone methylation can lead to aberrant chromatin remodeling and epigenetic changes that drive oncogenesis. Additionally, PRMTs can directly interact with key signaling pathways involved in cancer progression, such as the PI3K/Akt and MAPK pathways, thereby modulating cell survival and proliferation. In the context of cancer immunotherapy, PRMTs have emerged as critical regulators of immune responses. They modulate immune checkpoint molecules, including programmed cell death protein 1 (PD-1), through arginine methylation. Drug resistance is a significant challenge in cancer treatment, and PRMTs have been implicated in this phenomenon. PRMTs can contribute to drug resistance through multiple mechanisms, including the epigenetic regulation of drug efflux pumps, altered DNA damage repair, and modulation of cell survival pathways. In conclusion, PRMTs play critical roles in cancer pathogenesis, immunotherapy, and drug resistance. In this overview, we have endeavored to illuminate the mechanistic intricacies of PRMT-mediated processes. Shedding light on these aspects will offer valuable insights into the fundamental biology of cancer and establish PRMTs as promising therapeutic targets.

Overview of the Development of Protein Arginine Methyltransferase Modulators: Achievements and Future Directions.

Small Molecule Inhibitors of Protein Arginine Methyltransferases

Protein arginine methylation: from enigmatic functions to therapeutic targeting

Chemical probes and methods for the study of protein arginine methylation

Overview of PRMT1 modulators: Inhibitors and degraders

Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1

Protein arginine methyltransferases: promising targets for cancer therapy

A Patent Review of Arginine Methyltransferase Inhibitors (2010–2018)

Theoretical insights into catalytic mechanism of protein arginine methyltransferase 1

The regulation, functions and clinical relevance of arginine methylation

Dysregulation of arginine methylation in tumorigenesis

Protein arginine methylation of non-histone proteins and its role in diseases.

Targeting protein methylation: from chemical tools to precision medicines

Protein Arginine Methyltransferases (PRMTs): Orchestrators of Cancer Pathogenesis, Immunotherapy Dynamics, and Drug Resistance

Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation

Medicinal chemistry insights into PRMT5 inhibitors

Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)

Overview of the PRMT6 modulators in cancer treatment: Current progress and emerged opportunity

The Role of PRMT1 in Cellular Regulation and Disease: Insights into Biochemical Functions and Emerging Inhibitors for Cancer Therapy

Independent transcriptomic and proteomic regulation by type I and II protein arginine methyltransferases

The Development of Tetrazole Derivatives as Protein Arginine Methyltransferase I (PRMT I) Inhibitors